Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Neoplasms 3Breast Neoplasms 3Pancreatic Adenocarcinoma 2Stomatitis 1Radiation Fibrosis Syndrome 1Peripheral Nervous System Diseases 1Neuroma, Acoustic 1Neoplasms 1Inflammation 1Hypertension 1Glioblastoma 1Fibrosis 1Fallopian Tube Neoplasms 1Coronavirus Infections 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Camurati-Engelmann Syndrome 1COVID-19 1Brain Neoplasms 1

Interventions

fresolimumab 1bintrafusp alfa protein, human 1ascrinvacumab 1Trabedersen 1Temozolomide 1Sorafenib 1Radiotherapy 1Losartan 1Lomustine 1LY-2157299 1Drug Delivery Systems 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Camurati-Engelmann Syndrome × Losartan × Clear all
NCT05637216 2026-04-24

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Shaw Cancer Center

Phase 2 Recruiting
43 enrolled
Breast

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡